Clinical Trial

Pain AND Opioids After Surgery

Study acronym: PANDOS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2024 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to document the perioperative opioid use and its safety in the UK and countries in Europe and to describe its association with surgical complications, persistent pain and quality of life. In an international, prospective, observational cohort study, data about the perioperative pain management will be collected in all eligible hospitalised adult patients who undergo surgery in a designated "study week" in as many hospitals as possible in Europe. Baseline data will be collected, and participants followed up at one week, and at three and twelve months post-operatively. The primary outcome will be opioid use at three months after surgery. Secondary outcomes will include opioid use during the preoperative month (preoperative use), during surgery and up to one week after surgery (or discharge, whichever is earlier), and up to the end of the postoperative year. Additional secondary outcomes are the incidence of preoperative pain, persistent pain with/without the presence of neuropathic components, quality of life and surgical complications. The potential association between opioid use and pain outcomes will be investigated. This study could help to develop strategies to improve quality of care, through pain management, for patients undergoing surgery.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-05-23; most recent amendment 2024-12-18.
Status change: Not Yet Recruiting → Recruiting 2024-02-26
Trial Details
NCT Number NCT05877157
Lead Sponsor University of Aberdeen
Collaborators: European Society of Anaesthesiology and Intensive Care
Conditions Opioid Use, Pain, Chronic, Pain, Postoperative, Quality of Life
Enrollment 10,000 participants
Start Date 2023-09-25
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-12-24